Objective Maternal exposure to magnesium sulphate has a neuroprotective effect in
premature infants. This study aimed to examine this neuroprotective effect and the dose …

METHODS OF STUDY SELECTION: Randomized controlled trials comparing magnesium
sulfate with placebo/other treatment in patients at risk of preterm delivery were evaluated for …

OBJECTIVE: To systematically review rates of neurologic outcomes reported in childhood for
the preterm fetus exposed to antenatal magnesium sulfate. DATA SOURCES: We searched …

Objective To explore the association between antenatal magnesium sulfate (MgSO4),
mortality and incidence of intraventricular hemorrhage (IVH) in very low birth weight (VLBW) …

Objective: To determine whether in utero exposure to magnesium sulfate was associated
with increased neonatal morbidity and mortality among premature neonates, and …

[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm
newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective …

Introduction Magnesium sulfate is used world‐wide to treat pregnant women at imminent risk
of preterm delivery in order to protect the brain of the premature infant. Previous research …

Background Intrapartum magnesium sulfate administration is recommended for fetal
neuroprotection in women with imminent very preterm birth. However, previous studies have …

Background: Evidence that antenatal administration of magnesium sulfate (MgSO4) to
women in preterm labor may confer fetal neuroprotection is growing. MgSO4 crosses the …

Objectives. We tested the hypothesis that administration of magnesium sulfate in labor
protects against the development of neonatal brain lesions and cerebral palsy (CP) in low …